Anti-obesity Medication Use for Adolescent Metabolic and Bariatric Surgery Patients: A Systematic Literature Review.

Cureus · 2023 · PMC10801281 · PMID 38259385

Europe PMC DOI

hedged sentence

0.0980

closest p · 2.0× alpha

0.0980

boldest claim

The sentences

not quite significantp=0.098so close (0.05 < p ≤ 0.1)

Although these results were not quite significant (p=0.098), they show that exenatide treatment may help mitigate the rebound weight gain in adolescents after initial success in weight loss [ 20 ].

also in 653 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.